The authors found that an increased expression of GLUT-1 is associated with higher tumor grade (P=0.031), tumor size (P<0.001), and lymph node metastasis (P<0.001) as well as with shorter overall survival in OSCC [33]. Here, SLC2A1 is linked to metastatic malignant neoplasm in the lymph nodes.